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A variety of biological functions are regulated through ex- 
tracellular signals. One of the most unexpected responses 
to emerge has been receptor-mediated control of pro- 
grammed cell death, or apoptosis. Apoptosis is a morpho- 
logically defined process, characterized by the condensa- 
tion of the nucleus and cytoplasm and a distinctive pattern 
of chromosomal DNA fragmentation. 
Extracellular regulation of cell death is either protective 
or inductive. Most growth factors initiate signaling path- 
ways that protect cells from apoptosis. This is particularly 
evident in hematopoietic cells in which removal of growth 
factors is associated with the initiation of the cell death 
program. The signaling pathways that are involved in this 
type of regulation are not known. However, recent studies 
have implicated the Ras pathway (Kinoshita et al., 1995) 
phosphatidylinositol3-kinase (Yao and Cooper, 1995) or 
both. The targets of these pathways are likely to involve 
regulation of the Bcl-2 family of proteins, which function 
to suppress or activate this cell death program (Oltvai and 
Korsmeyer, 1994). 
In contrast with growth factors, Fas ligand (FasL) and 
the tumor necrosis factors (TNFs) rapidly and dominantly 
induce cell death (Nagata and Golstein, 1995). FasL- 
induced cell death is required for the normal elimination 
of potentially autoreactive peripherial T cells and contributes 
to T cell-mediated cytotoxicity (Nagata and Golstein, 1995). 
By contrast, the absence of the ~55 receptor for TNF 
(TNFRl) is associated with the inability to generate an 
appropriate host defense response against certain patho- 
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gens (Pfeffer et al., 1993), without affecting T cell matura- 
tion or selection. 
FasL and TNF mediate their effects through interaction 
with structurally related receptors belonging to the TNFR 
superfamily (Smith et al., 1994). Most of these receptors 
recognize ligands that play critical roles as costimulators 
in immur s responses rather than that induce cell death. 
Consequently, it can be hypothesized that the FasL recep- 
tor (Fas) and TN FRl evolved to couple to a death pathway. 
As indicated in Figure 1, induction of cell death requires 
a unique cytoplasmic motif found in both TNFRl and Fas, 
coined the death domain (Tartaglia et al., 1993; ltoh and 
Nagata, 1993). This domain shows some similarity to a 
motif in the Drosophila protein reaper (Golstein et al., 
1995). In Drosophila, most, if not all, programmed cell 
death requires reaper, a 65 amino acid cytoplasmic poly- 
peptide (White et al., 1994). Reaper is specifically ex- 
pressed in cells doomed todie, and theonsetof expression 
precedes the first morphological changes of apoptosis by 
l-2 hr. However, a mammalian homolog of reaper has 
yet to be identified. 
Fas also contains a negative regulatory domain, a “sal- 
vation” domain, at the carboxyl terminus that, structurally, 
is not present in TNFRl (Itoh and Nagata, 1993). A recent 
report (Sato et al., 1995) demonstrated that the 15 amino 
acid carboxyl terminus of Fas associates with a protein- 
tyrosine phosphatase that had previously been identified 
in basophils (PTP-BAS). Association in cells under normal 
conditions was not examined, and consequently the effect 
of FasL on association is not known. Importantly, cells that 
are resistant to FasL killing express PTP-BAS, whereas 
sensitive cells do not. Introduction of PTP-BAS into sensi- 
tive cells confers resistance. 
Fas- and TNF-induced cell death is detectable within 
a couple of hours and does not require macromolecular 
synthesis, and cytoplasmic changes can occur in the ab- 
sence of the nucleus (Nagata and Golstein, 1995). These 
Figure 1. The Structure of Proteins with Death 
Domains 
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At top are shown the structures of the Fas and 
TNFRl receptors, and beneath is a schematic 
of the structures of the Fas- and TNFRl- 
interacting proteins TRADD, FADD, and RIP. 
For the receptors, homologous domains are 
shown as open boxes and cysteine residues 
are indicated by vertical lines. TM indicates the 
transmembrane region of the receptors. Stip 
pled boxes in the cytoplasmic region indicate 
the death domain (DD). TRADD, FADD, and 
FADD 
RIP all interact with these receptors through 
a death domain homologous (DDH) region. 
Hatched boxes indicate regions of these pro- 
RIP 
Reaper 
teins sufficient for inducing apoptosis. For com- 
parison, beneath is shown the structure of the 
Drosophila reaper protein, which has some 
similarity to the TNFRl death domain (Golstein 
et al., 1995). 
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results indicate that Fas- or TNF-induced signals modulate 
latent cytoplasmic effector molecules. Current evidence 
suggests both distinct and similar death Signaling path- 
ways (Schulze-Osthoff et al., 1994; Wong and Goeddel, 
1 g94), although death induced by TNF issomewhat slower 
than that induced by Fas. In spite of the lack Of catalytic 
domains, both receptors have been reported to couple 
ligand binding to induction of tyrosine and serine/threo- 
nine phosphorylations (Eischen et al., 1994; Darnay et al., 
1994). A role for tyrosine phosphorylation is supported by 
the negative influence of the PTP-BAS tyrosine phospha- 
tase on FasL-induced apoptosis (Sato et al., 1995). Simi- 
larly, both FasL and TNF share the ability to induce sphin- 
gomyelinases, and evidence has been presented to 
suggest that the product, ceramide, is an inducer of cell 
death (Wiegmann et al., 1994; Nagataand Golstein, 1995). 
Recent evidence also implicates cysteine proteases in 
FasL- and TNF-induced cell death. In Caenorhabditis eleg- 
ans the ted-3 gene, which is required for programmed cell 
death, encodes a protease related to the interleukin-l-5 
converting enzyme (ICE). ICE is a member of a novel fam- 
ily of structurally related proteases. Expression of ICE or 
of the related protease Ich-l/Nedd-2 is sufficient to induce 
cell death (Kumar et al., 1994; Wang et al., 1994). Deletion 
of the ICE gene in mice renders thymocytes resistant to 
Fas-induced apoptosis (Kuida et al., 1995) although dexa- 
methasone- or y-irradiation-induced thymocyte apoptosis 
is normal in ICE-deficient mice (Li et al., 1995). Last, crmA, 
a product of the cowpox virus that inhibits cysteine prote- 
ases, including ICE, inhibits both FasL- and TNF-induced 
apoptosis (Tewari and Dixit, 1995; Enari et al., 1995). 
How these pathways are integrated to the FasL and TNF 
receptors are unknown. It is likely that the primary function 
of the ligands is to mediate receptor aggregation. This is 
supported by the crystal structure of ligand-bound TNFRl 
(Banner et al., 1993). By analogy to a variety of receptor 
systems, it can be hypothesized that aggregation of the 
receptor activates receptor-associated effecters or facili- 
tates their recruitment to the receptor complex. Therefore, 
the identification of proteins that directly bind to the recep- 
tor cytoplasmic domains is critical. The advent of the yeast 
two-hybrid technique has provided an elegant means of 
cloning the genes for proteins that can associate with a 
target protein. 
Once gene products have been identified that interact 
in yeast, a number of criteria must be applied to establish 
that the interactions have biological relevance. The most 
important criterion is that the interactions can be demon- 
strated in appropriatecells under physiological conditions. 
In lieu of this, other criteria have been applied. These in- 
clude the demonstration that the interactions require (or 
are ablated by) domains or mutations that have been func- 
tionallydefined. Alternatively, the properties of the isolated 
gene are consistent with the biology either based on motifs 
or biological activity (i.e., the “smells right” criterion). 
In this issue of Cell, three groups report the use of the 
yeast two-hybrid method to clone genes encoding proteins 
that associate with the cytoplasmic domains of TNFRl 
or Fas. Remarkably, each group identified dramatically 
different genes (TRADD in Hsu et al., 1995; FADD in Chin- 
naiyan et al., 1995; RIP in Stanger et al., 1995). FADD was 
independently cloned, with the same strategy, by another 
group and termed MORTl (Boldin et al., 1995b). Indeed, 
the only structural similarity is a shared motif that has 
homology with the death domains of the receptors (i.e., 
they all smell right). Although none of the reports establish 
receptor associations under physiological conditions, each 
provides some tantalizing observations to suggest biologi- 
cal importance. 
The predicted protein structures for TRADD, FADD, and 
RIP are shown in Figure 1, where they are compared with 
the receptors and reaper. Each was isolated through a 
carboxy-terminal region that associates with the receptor 
cytoplasmicdomain used as bait. These regions have con- 
siderable homology to the Fas and TNFRl death domains. 
Mutations within the death domains of the receptors, in- 
cluding the Ipr mutation that is known to inactivate Fas, 
disrupt association of FADD, RIP, and TRADD with the 
receptors. The ability to identify proteins that contain death 
domain-related sequences may not be too surprising, 
since the death domains of the Fas and TNFRl receptors 
are known to dimerize in the yeast two-hybrid system (Bol- 
din et al., 1995a; Song et al., 1994). Indeed, most clones 
obtained were the receptors themselves owing to either 
their relative abundance or affinities. Among the genes, 
FADD and TRADD uniquely associate with Fas and 
TNFRl, respectively, while RIP associates with Fas and, 
to a lesser extent, TNFRl. Obviously it will be important 
to examine their ability to interact with each other. 
The alignments of the sequences having similarity to 
the receptor death domains are shown in Figure 2, and 
the extent of identity and similarity is summarized in Table 
1. Also shown is the alignment and identity and similarity 
of the regions to ankyrin. The similarity to ankyrin was 
identified in a computer search. However, whether this 
sequence similarity has functional significance for either 
association or cell death is not known. Although, FADD 
and RIP were specifically isolated with the Fas death do- 
main as bait, the associating domains of TRADD, FADD, 
and RIP are most similar to the TNFRl death domain. 
The highest similarity exists between RIP and FADD, two 
proteins that otherwise are quite dissimilar in structure. 
All domains show similar, albeit limited, similarity to a motif 
found in the middle of reaper. Beyond the associating do- 
mains, TRADD, FADD, and RIP are unrelated. FADD (23 
kDa) and TRADD (34 kDa) contain amino-terminal regions 
that lack defined protein motifs. In contrast, RIP (74 kDa) 
contains an amino-terminal kinase domain that has se- 
quences consistent with it being either a protein-tyrosine 
or serinelthreonine kinase. Catalytic activity for the RIP 
kinase domain has not been established, and the kinase 
domain does not contain the invariant DFG motif found 
in subdomain VII in the activation loop of all kinases. How- 
ever, the presence of a kinase domain is intriguing, since 
studies have suggested that Fas and TNF induce protein 
phosphorylations. 
From the above, the two-hybrid system can be con- 
cluded to have faithfully identified diverse proteins that 
contain a motif known to mediate interactions. Are these 
associations relevant to FasL- or TNF-induced cell death? 
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Reaper 1 
TRADD 211 
FADD 104 
Mouse RIP 575 
Human RIP 201 
Mouse FAS 207 
Human FAS 220 
Mouse TNFRl 333 
Human TNFRl 334 
Ankyrin 1 1400 
Reaper 34 
TRADD 251 
FADD 144 
Mouse RIP 616 
Human RIP 332 
Mouse FAS 248 
Human FAS 261 
Mouse TNFRl 374 
Human TNFRl 395 
Ankyrin 1 1450 
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Figure 2. Sequence Homology in the Death Domains 
Alignment for each protein begins at the indicated residue. Residues identical in three or more proteins are shown in bold, and those residues 
considered conserved in three or more proteins are boxed and hatched. Similar amino acids were defined as follows: A, G; S, T; E, D; R, K, H; 
Q, N; V, I, L, M; Y, F; W; P; C. Arrow indicates position of the Ipr mutation in murine Fas (Nagata and Golstein, 1995). 
The single critical observation to support a functional rela- 
tionship to cell death is the demonstration that TRADD, 
FADD, and RIP, when transiently overexpressed in cells, 
all induce apoptosis. This property is shared with the cyto- 
plasmic death domain of TNFRl, and the Fas death do- 
main can potentiate the cytotoxicity of TNFRl (Boldin et 
al., 1995a). Moreover, a number of unrelated proteins can 
induce apoptosis. Like FasL- and TNF-induced cell death 
(Tewari and Dixit, 1995) TRADD- and FADD-induced 
apoptosis is inhibitable by crmA. However, it should be 
noted that crmA inhibits several forms of cell death, in- 
cluding death following the removal of survival factors 
(Gagliardini et al., 1994). Importantly, the overexpression 
of TRADD was also demonstrated to induce NF-KB, a 
property that is shared with TNFRl but that is reported 
not to be shared with Fas (Nagata and Golstein, 1995). 
Unlike apoptosis, activation of NF-KB is not inhibited by 
crmA. Thus, cell death can be dissociated from NF-KB 
activation, demonstrating that NF-KB activation, in this 
system, is not due to secondary signals emanating from 
dying cells. 
Has the two-hybrid system simply identified proteins 
with association domains that, when overexpressed, fortu- 
itously induce apoptosis? Similar to the death domains of 
Fas and TNFRl, the association domain of TRADD func- 
tions as a death domain to induce apoptosis. However, 
while deletion of the death domain of RIP eliminates its 
ability to induce apoptosis, the RIP death domain itself 
has only limited activity. Moreover, the death domain of 
FADD does not mediate cell death, but rather apoptosis 
is induced by its unique amino-terminal region. Thus, in 
striking contrast with TRADD, FADD and RIP must be hy- 
pothesized to contain distinctive effector domains for 
apoptosis. Therefore, the existence of a simple “deadly” 
domain for apoptosis is ruled out and more complex mod- 
els must be evoked. 
Table 1. Identity and Similarity of “Death” Domains 
Reaper 
TRADD 
FADD 
hRlP 
hFas 
hTNFR1 
TRADD FADD hRlP hFAS hTNFR1 hAnkyrin 1 
10.8% 7.7% 9.2% 6.1% 
(16.9%) (13.8%) (12.3%) (12.3%) 
- 14.9% 18.2% 11.7% 
(24.3%) (28.6%) (22.1%) 
- - 36.5% 17.6% 
(54.1%) (29.7%) 
- - - 27.3% 
(32.5%) 
15.4% 
(21.5%) 
24.7% 
(35.1%) 
28.4% 
(30.2%) 
27.3% 
(42.9%) 
19.5% 
(35.1%) 
- 
7.7% 
(16.9%) 
10.2% 
(29.8%) 
28.8% 
(32.0%) 
27.6% 
(40.8%) 
13.8% 
(21.3%) 
20.5% 
(40.3%) 
Similarities are given beneath amino acid identities in parentheses. Similar amino acids were defined as follows: A, G; S, T; E, D; R, K, H; Q, N; 
V, I, L, M; Y, F; W; P; C. 
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What models can be evoked? One possibility, of many, 
is that effector proteins are tethered to the Fas and TNFRl 
receptors through their death domains. Ligand binding 
causes receptor aggregation, converting receptor associ- 
ations from heterotypic to homotypic and releasing the 
effecters of cell death. In addition, one could envision that 
the released effecters may be activated by hetero- or ho- 
modimerization through their death domains. Overexpres- 
sion of death domains that interact with the receptor with 
high affinity could displace effecters. By contrast, effecters 
that associate with the receptors with lower affinities may 
not have death domains that can displace and directly 
induce apoptosis. Rather, their ability to induce death by 
overexpression may be dependent upon their effector do- 
mains. 
Clearly, a variety of additional models could be envi- 
sioned. However, at this point, it is essential to determine 
whether TRADD, FADD, and RIP associate with the recep- 
tor under normal conditions and whether association is 
regulated by ligand. Also, do TRADD, FADD, or RIP form 
complexes in cells, and what is the consequence of ligand 
binding on these interactions? Do FADD and RIP act to- 
gether in Fas signaling? Does RIP have kinase catalytic 
activity, and what is the consequence of ligand binding 
on RIP phosphorylation and activity? Last, doesthedisrup- 
tion of any of the genes in mice produce a phenotype 
consistent with a role in apoptosis? Obviously, there are 
a number of issues that must be addressed before it is 
established that TRADD, FADD, or RIP plays a central 
role in TNFRl- or Fas-mediated cell death or whether the 
two-hybrid system, coupled with death assays, has led us 
down the yellow brick road. The final deadly thought is 
that since the three groups did not isolate the same gene, 
statistically one might conclude that more genes are in 
the offing. 
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